IP Library › Granted Patent US 11,752,098
Granted Patent B2
US 11,752,098 · App. 16/755,191 · Granted Sep 12, 2023

Core-shell microneedle patch for H

Inventors: Zhen Gu (Los Angeles, CA); Jinqiang Wang (Raleigh, NC)
Assignee: North Carolina State University
A61K9/0021A61K9/1075A61P3/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,752,098
App. No.
16/755,191
Granted
Sep 12, 2023
Kind
B2
Abstract

Disclosed are compositions and methods for microneedle patches comprising diblock copolymer micelles designed for pH cascade and H 2 O 2 triggered insulin delivery.

Claims (8)

1. A microneedle patch comprising diblock copolymer micelles; wherein the diblock copolymer micelles comprise separately insulin and a glucose responsive enzyme; wherein the diblock copolymer comprises mPEG n -poly(2-(dimethylamino)ethyl methacrylate-4-(bromomethyl)phenylboronic acid) m of formula 1 shown below:

(MPEG n -P(DMAEMA-PBA) m ); wherein n can be between 1 and 8,000; and wherein m can be between 1 and 18,000; wherein the microneedles are coated with H 2 O 2 scavenging enzyme; wherein the diblock copolymer micelles further comprise poly(vinyl alcohol) methacrylate (m-PVA); and wherein the insulin dissociates from the micelle in an acidic and oxidative environment.

2. The microneedle patch of claim 1 , wherein the glucose responsive enzyme is glucose oxidase.

3. The microneedle patch of claim 1 , wherein the H 2 O 2 scavenging enzyme comprises catalase.

4. The microneedle patch of claim 1 , wherein the microneedles comprise a core and the diblock copolymer micelles are crosslinked to the microneedle core via non-cleavable covalent bond.

5. A self-regulating insulin delivery system comprising the microneedle patch of claim 1 .

6. A method of treating hyperglycemia in a subject comprising administering to the subject the microneedle patch of claim 1 .

7. The method of claim 6 , wherein the hyperglycemia is a symptom of diabetes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2020
From: GU, ZHEN; WANG, JINQIANG
To: NORTH CAROLINA STATE UNIVERSITY
Reel/Frame 052378/0545 →
Continuity (2)
Provisional Application 62570498 · Oct 10, 2017
Related Publication 20210186865A1 · Jun 24, 2021
Cited By (1)
US 12,746,277